Table 1.
Patients' characteristics (N = 149)
| Characteristics | Pancreatic cancera (n = 105) | Nonmalignant pancreatic massb (n = 44) |
| Age, mean ± SD | 58.38 ± 11.01 | 52.66 ± 13.81 |
| Sex, n (%) | ||
| Male | 69 (65.71) | 36 (81.82) |
| Female | 36 (34.29) | 8 (18.18) |
| Location of mass, n (%) | ||
| Head/uncinate | 70 (66.67) | 38 (86.36) |
| Body/tail | 35 (33.33) | 6 (13.64) |
| CA19-9, n (%) | ||
| ≥37 U/mL | 75 (71.43) | 10 (22.73) |
| <37 U/mL | 30 (28.57) | 34 (77.27) |
| CEA, n (%) | ||
| ≥10 ng/mL | 32 (30.48) | 10 (22.73) |
| <10 ng/mL | 73 (69.52) | 34 (77.27) |
| Surgery, n (%) | ||
| Yes | 24 (22.86) | 5 (11.36) |
| No | 81 (77.14) | 39 (88.64) |
CA19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen.
a
Pancreatic cancer including 102 ductal adenocarcinoma and 3 diagnosed acinar cell carcinoma.
b
Nonmalignant pancreatic mass including 26 autoimmune pancreatitis, 10 chronic pancreatitis, and 3 pancreatic tuberculosis.